|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | HER2 in gastric cancer: Comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays显示文摘AIM:To compare the performance of three commercially available anti-human epidermalgrowth factor receptor 2(HER2)antibodies in whole-tissue sections and tissue microarrays(TMAs)of a series of gastric tumors.METHODS:We present a comparative analysis of three anti-HER2 antibodies(HercepTest,4B5 and SP3)using TMA and whole-tissue sections prepared from the same paraffin blocks of 199 gastric adenocarcinomas operated upon between January 2004 and December2008 at a Brazilian cancer hospital.The data on the patients’age,sex,the anatomical location of the tumor and the Lauren’s histological classification were collected from clinical and pathological records.The immunohistochemical(IHC)results were examined by two pathologists and the cases were classified as positive(3+),equivocal(2+)and negative(0 or 1+),according to the criteria of the IHC scoring system of gastric cancer.TMAs and whole-tissue sections were evaluated separately and independently.All cases yielding discordant IHC results and/or scored as 2+were subjected to dual-color in situ hybridization in order to determine the final HER2 status.Besides determining the sensitivity and predictive value for HER2-positive status,we measured the accuracy of each antibody by calculating the area under the receiver operating characteristic(ROC)curve.The agreement between the results obtained using the TMAs and those obtained using the whole-tissue sections was assessed by means of Kappa coefficient.RESULTS:Intratumoral heterogeneity of HER2 expression was observed with all antibodies.HER2-positive expression(3+)in the whole-tissue sections was observed in 23 cases(11.6%)using the 4B5 antibody,in 18 cases(9.1%)using the SP3 antibody and in 10 cases(5.1%)using the HercepTest antibody.In the TMAs,11 positive cases(5.6%)were identified using SP3 antibody,9(4.6%)using the 4B5 antibody and 6(3%)using the HercepTest antibody.The sensitivity using whole-tissue sections and TMA,respectively,was 95.2%and 42.9%with 4B5,90.5%and 66.7%with SP3 and 47.6%and42.9%with HercepTest.The accuracy,calculated from the area under the ROC curve,using whole-tissue sections and TMA,respectively,was 0.91 and 0.79 by 4B5,0.86 and 0.80 by SP3 and 0.73 and 0.71 by HercepTest.The concordance of the results obtained using wholetissue sections and TMA was 97.4%(Kappa 0.75)using HercepTest,85.6%(Kappa 0.56)using SP3 and 84.1%(Kappa 0.38)using 4B5.CONCLUSION:The use of the 4B5 antibody on wholetissue sections was the most accurate IHC method for evaluating HER2 expression in gastric adenocarcinoma. | Lucas Faria Abraho-Machado Alexandre Andrade dos Anjos Jácome Durval Renato Wohnrath José Sebastio dos Santos Estela Cristina Carneseca José Humberto Tavares Guerreiro Fregnani Cristovam Scapulatempo-Neto | 2013 | World Journal of Gastroenterology2013，19，38： | 12 |
| 2 | Personalized medicine in gastric cancer:Where are we andwhere are we going?显示文摘Despite improvements in adjuvant therapies for gastric cancer in recent years, the disease is characterized by high recurrence rates and a dismal prognosis. The major improvement in the treatment of recurrent or metastatic gastric cancer in recent years has been the incorporation of trastuzumab, a monoclonal antibody that inhibits human epidermal growth factor receptor 2(HER2) heterodimerization, after the demonstrated predictive value of the overexpression and/or amplification of this receptor. Beyond HER2, other genetic abnormalities have been identified, and these mutations may be targetable by tyrosine kinase inhibitors or monoclonal antibodies. The demonstration of four distinct molecular subtypes of gastric cancer by the Cancer Genome Atlas study highlight the enormous heterogeneity of the disease and its complex interplay between genetic and epigenetic alterations and provide a roadmap to implement genome-guided personalized therapy in gastric cancer. In the present review, we aim to discuss, from a clinical point of view, the genomic landscape of gastric cancer described in recent studies, the therapeutic insights derived from these findings, and the clinical trials that have been conducted and those in progress that take into account tailored therapies for gastric cancer. | Alexandre A Jácome Anelisa K Coutinho Enaldo M Lima Aline C Andrade JoséSebastião dos Santos | 2016 | World Journal of Gastroenterology2016，22，3： | 2 |
| 3 | Prognostic value of epidermal growth factor receptors in gastric cancer: a survival analysis by Weibull model incorporating long-term survivors显示文摘 | Alexandre Andrade Anjos Jácome Durval R. Wohnrath Cristovam Scapulatempo Neto Estela C. Carneseca Sérgio V. Serrano Luciano Souza Viana Jo?o S. Nunes Edson Z. Martinez José Sebasti?o Santos | 2014 | Gastric Cancer2014，，1： | 2 |
| 4 | Inflammatory reaction after sirolimus-eluting stent implant 显示文摘 | Comes WJ Giannotti-Filho O Hossne NA Jr | 2005 | Ann Thorac Surg2005，80，5： | 1 |
| 5 | Long-term follow-up after endoscopic resection of gastric superficial neoplastic lesions in Portugal显示文摘 | Pedro Pimentel-Nunes Francisco Mour?o Nuno Veloso Luís Afonso Manuel Jácome Luís Moreira-Dias Mário Dinis-Ribeiro | 2014 | Endoscopy2014，，： | 1 |
| 6 | Empirical antimicrobial monotherapy in patients after high - dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial 显示文摘 | Reich G Comely O Sandherr M | 2005 | Br J Hematol2005，130，： | 1 |
| 7 | Leaching of aluminum from cooking pans and food containers 显示文摘 | Verissimo J Comes O Comes M | 2006 | Sensor Actuator B2006，118，12： | 1 |
| 8 | Severe pneumonia and human bocavirus in adult显示文摘 | Kupfer B Vehreschiid J Comely O | 2006 | Emerging infectious diseases2006，12，10： | 1 |
| 9 | The effect of sliding speed and temperature on the tribological behavior of carboncarbon composites 显示文摘 | J R Comes O M Silva C M Silva | 2001 | Wear2001，249，： | 1 |
| 10 | Dissemina- ted Neocosrnospora vasinfecta infection in a patient with acute nonlymphocytie leukemia显示文摘 | Comely O A Chemnitz J Broehhagen H G | 2001 | Emerging Infectious Diseases2001，7，1： | 1 |
| 11 | Coronal Microleakage of Three Temporary Restorative Materials:An In Vitro Study显示文摘 | Banegas G Comelis H | 2004 | The American Association of Endodontists2004，30，8： | 1 |
| 12 | Outcomes of nosocomial bloodstream infections in adult neutropenic patients:a prospective cohort and matched case-oontrol study显示文摘 | Wisplinghoff H Comely O A Moser S | 2003 | Infect Control Hosp Epidemiol2003，24，12： | 1 |
| 13 | Leaf gas exchange, chlorophyll fluorescence and growth responses of Genipa americana seedlings to soil flooding 显示文摘 | Mielke M S Almeida A F Comes F P Aguilar M A G Mangabeira P A O | 2003 | Environ Exp Bot2003，50，： | 1 |
| 14 | CD25^+ regulatory T cell depletion augments immunotherapy of micrometas tases by an IL- 21-secreting cellular vaccine显示文摘 | Comes A Rosso O Orengo A M | 2006 | Immunology2006，176，： | 1 |
| 15 | Severe pneumonia and human bocavirus in adult显示文摘 | Kupfer B Vehreschild J Comely O | 2006 | Emerg Infect Dis2006，12，10： | 1 |
| 16 | The health of the works in a rapidly developing country: effects of occupational exposure to noise and heat 显示文摘 | Comes L Lloyd O Norman N | 2002 | Occup Med(Lond)2002，52，3： | 1 |
| 17 | Serotonin transporter gene polymorphisms in alcohol dependence显示文摘 | Thompson MD Gonzalez N Nguyen T Comings DE George SR O'Dowd BF | | 0，，02： | 1 |
| 18 | Censoring estimators of a positive tail index显示文摘 | O LIVEIRA O | 2003 | Statistic and Probability Lettters2003，65，： | 1 |
| 19 | An open-label ran- domized trial comparing it raconazole oral solution with flucon- azole oral so lution for primary prophylax is of fungal infections in patients with haematological malignancy and profound neutro- penia 显示文摘 | Glasmacher A Comely O Ullmann A J | 2006 | J Antimicrob Chemother2006，57，： | 1 |
| 20 | Genotoxicity of cop- per oxide and silver nanoparticles in the mussel My~'lus galloprovincialis 显示文摘 | Comes T Arafijo O Pereira R | 2013 | Marine Environmental Research2013，84，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员